USPatent applicationPatented

Process for preparing dihydridodicyanoborate salts

Granted 6 Jan 2015 · no office action yet

Life of the application

7 dated events
⤢ drag to zoom20122014201620182020202220242026202820302032ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

The invention relates to a process for the preparation of alkali-metal salts with dihydridodicyanoborate anions by reaction of alkali-metal tetrahydridoborates or trihydridocyanoborates with trialkylsilyl cyanide and further reaction thereof in metathesis reactions.

Description

16 parts
›The invention relates to a process for the…

The invention relates to a process for the preparation of alkali-metal salts with dihydridodicyanoborate anions by reaction of alkali-metal tetrahydridoborates or trihydridocyanoborates with trialkylsilyl cyanide and further reaction thereof in metathesis reactions.

A synthesis of lithium [BH 2 (CN) 2 ] is known, for example, from B. Györi et al, Journal of Organometallic Chemistry, 1983, 255, 17-28, where oligomeric 1/n (BH 2 CN) n is reacted with LiCN*CH 3 CN in dimethyl sulfide.

A synthesis of sodium [BH 2 (CN) 2 ] is known, for example, from B. F. Spielvogel et al, Inorg. Chem. 1984, 23, 3262-3265, where a complex of anilline with BH 2 CN is reacted with sodium cyanide. Tetrahydrofuran is described as solvent. P. G. Egan et al, Inorg. Chem. 1984, 23, 2203-2204, also describe the synthesis of the dioxane complex Na[BH 2 (CN) 2 ]*0.65 (dioxane) based on the papers by Spielvogel et al., using a different work-up variant.

M. K. Das et al, Bull. Chem. Soc. Jpn., 1990, 63, 1281-1283, report on reactions of the dioxane complex Na[BH 2 (CN) 2 ]*0.65 (dioxane), prepared by the method of P. G. Egan et al, with amine hydrochlorides or phosphine hydrochlorides. In general, the metathesis product is formed here, i.e. quaternary ammonium or phosphonium dicyanodihydridoborates, such as, for example, propylammonium dicyanodihydridoborate, bis(isopropyl)ammonium dicyanodihydridoborate, tripropylammonium dicyanodihydridoborate, s-butylammonium dicyanodihydridoborate, dibutylammonium dicyanodihydridoborate, bis(isobutyl)ammonium dicyanodihydridoborate, triphenylphosphonium dicyanodihydridoborate, diethylammonium dicyanodihydridoborate or triethylammonium dicyanodihydridoborate.

Compounds with organic cations and dicyanodihydridoborate anion are known, for example, from Zhang Y. and Shreeve J. M., Angew. Chem. 2011, 123, 965-967, where the compounds were prepared by anion exchange with Ag[BH 2 (CN) 2 ]. A synthesis of this silver dicyanodihydridoborate is not described.

However, there continues to be a demand for economical alternative synthesis methods for the preparation of this interesting class of salts with dicyanodihydridoborate anion, in particular of alkali-metal, ammonium or tetraalkylammonium salts.

The object of the present invention is therefore to develop an alternative preparation process which gives the desired salts in good yield and starts from readily accessible starting materials.

Surprisingly, it has been found that alkali-metal tetrahydridoborates or cyanotrihydridoborates are excellent starting materials for the synthesis of the desired dicyanodihydridoborates, which are readily accessible or commercially available.

The invention therefore relates to a process for the preparation of salts of the formula I

Me + [BH 2 (CN) 2 ] −   I,

where Me + is a lithium, potassium, sodium, caesium or rubidium cation, by reaction of a salt of the formula II or of the formula III

Me + [BH 4 ] −   II,

Me + [BH 3 (CN)] −   III,

where

Me + has an above-mentioned meaning, with a trialkylsilyl cyanide, where the alkyl group of the trialkylsilyl cyanide in each case, independently of one another, denotes a linear or branched alkyl group having 1 to 4 C atoms.

The process according to the invention is surprising, since a similar reaction of the diborane B 2 H 6 with trialkylsilyl cyanide merely gives a complex (CH 3 ) 3 SiCN*BH 3 , which decomposes thermally into gaseous (CH 3 ) 3 SiH and solid BH 2 CN in polymeric form. (E. C. Evers et al., J. of American Chemical Society, 81, 1959, 4493-4496).

The process according to the invention can also be used for the synthesis of ammonium or tetraalkylammonium dicyanodiydridoborates, where the alkyl group of the tetraalkylammonium cation in each case, independently of one another, denotes a linear or branched alkyl group having 1 to 12 C atoms. Preferred tetraalkylammonium cations are the tetramethylammonium, tetraethylammonium or tetrabutylammonium cation.

A straight-chain or synonymously linear or branched alkyl group having 1 to 4 C atoms is, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl or tert-butyl. A linear or branched alkyl group having 1 to 12 C atoms encompasses the embodiments of the linear or branched alkyl group having 1 to 4 C atoms and, for example, n-pentyl, n-hexyl, n-heptyl, n-octyl, ethylhexyl, n-nonyl, n-decyl, n-undecyl or n-dodecyl.

The alkyl groups of the trialkylsilyl cyanide may be identical or different. The alkyl groups are preferably identical. Examples of trialkylsilyl cyanides are therefore trimethylsilyl cyanide, triethylsilyl cyanide, triisopropylsilyl cyanide, tripropylsilyl cyanide or tributylsilyl cyanide. Particular preference is given to the use of trimethylsilyl cyanide, which is commercially available or can also be prepared in situ.

The compounds of the formula II or III are commercially available or accessible by known synthesis processes. The cyanotrihydridoborates of the formula III are prepared, for example, in accordance with Wittig et al., Liebigs Ann. Chem. 1951, 573, 195, by reaction, for example, of lithium borohydride with prussic acid with formation of hydrogen in diethyl ether. R. C. Wade et al., Inorganic Chemistry, 9 (9), 1970, 2146-2150, describe the synthesis of sodium trihydridocyanoborate by reaction of sodium borohydride with prussic acid in THF. DE 2028569 A (1971) and U.S. Pat. No. 3,697,232 A (1972) describe the synthesis of compounds of the formula (III), as described above, in solvated form by reaction of a metal tetrahydroborate, Me[BH 4 ], with HCN in anhydrous organic solvents.

R. O. Hutchins et al., J. of American Chemical Society, 95 (18), 1973, 6131-6133, describes the synthesis of tetrabutylammonium trihidridocyanoborate by anion exchange, where tetrabutylammonium hydrogensulfate is reacted with sodium trihydridocyanoborate. Tetrabutylammonium trihydridocyanoborate is a solid having a melting point of 144-145° C.

Preference is given to the use of compounds of the formula II or III in which Me + is a lithium, sodium or potassium cation, particularly preferably a sodium or potassium cation, very particularly preferably a sodium cation.

›Very particularly preferred compounds of the formula II…

Very particularly preferred compounds of the formula II or III for the synthesis of the compounds of the formula I, as described above, should therefore be selected from sodium tetrahydridoborate (or synonymously sodium borohydride) or sodium trihydridocyanoborate.

Compounds of the formula II, as described above, or preferred compounds of the formula II are especially preferably employed in the process according to the invention.

The preparation according to the invention of the compounds of the formula I, as described above, is preferably carried out at temperatures between 10° and 200° C., in particular between 15° and 150° C., particularly preferably at 100° to 150° C.

The reaction of the compounds of the formula II or of the formula III, as described above, with the trialkylsilyl cyanide can be carried out without protective-gas atmosphere. However, the reaction is preferably carried out under dried air or in an inert-gas atmosphere.

The reaction of the compounds of the formula II or of the formula III, as described above, with the trialkylsilyl cyanide is preferably carried out without solvent. However, the reaction in the presence of an organic solvent, for example in the presence of nitriles or ethers, is possible. A preferred nitrile is acetonitrile. Preferred ethers are tetrahydrofuran, diethyl ether or di methoxyethane.

In a further embodiment, the trialkylsilyl cyanide used is prepared in situ from an alkali-metal cyanide and a trialkylsilyl chloride in the presence of an alkali-metal iodide or fluoride and optionally iodine, before the reaction with a compound of the formula II or III, as described above. Sodium cyanide and sodium iodide or potassium cyanide and potassium iodide is preferably used here, where the alkali-metal iodide is preferably added in a molar amount of 0.1 mol/l, based on 1 mol/l of alkali-metal cyanide and trialkylsilyl chloride. In general, this preparation process is based on the description by M. T. Reetz, I. Chatziiosifidis, Synthesis, 1982, p. 330; J. K. Rasmussen, S. M. Heilmann and L. R. Krepski, The Chemistry of Cyanotrimethylsilane in G. L. Larson (Ed.) “Advances in Silicon Chemistry”, Vol. 1, p. 65-187, JAI Press Inc., 1991 or WO 2008/102661 A1.

The invention therefore also relates to a process for the preparation of compounds of the formula I, as described above, characterised in that the trialkylsilyl cyanide is prepared in situ from an alkali-metal cyanide and a trialkylsilyl chloride in the presence of an alkali-metal iodide and optionally iodine before the reaction with a compound of the formula II or formula III.

When carrying out the preparation according to the invention of compounds of the formula I, as described above, it is possible to purify the compounds obtained from the reaction and to employ them as isolated, pure compound in a salt-exchange reaction or metathesis reaction, preferably with compounds of the formula IV, as described below.

However, it is advantageous, in a further embodiment, for the compound of the formula I not to be worked up to give the pure substance, but instead merely the byproducts which are insoluble in organic solvents or are volatile, such as, for example, trialkylsilane or an excess of trimethylsilyl cyanide, to be separated off and the compound of the formula I to be reacted, without further purification to give the pure substance, with a compound of the formula IV, as described below.

The invention likewise furthermore relates to a process as described above in detail, in which, in a subsequent reaction, a compound of the formula I is reacted with a compound of the formula IV

KtA  IV

in which

Kt has the meaning of an organic cation or a metal cation, where the cation Kt does not correspond to the cation Me + employed in the compound of the formula I and

the anion A denotes

F − , Cl − , Br − , I − , OH − , [HF 2 ] − , [CN] − , [SCN] − , [R 1 COO] − , [R 1 OC(O)O] − , [R 1 SO 3 ] − , [R 2 COO] − , [R 2 SO 3 ] − , [R 1 OSO 3 ] − , [PF 6 ] − , [BF 4 ] − , [HSO 4 ] 1− , [NO 3 ] − , [(R 2 ) 2 P(O)O] − , [R 2 P(O)O 2 ] 2− , [(R 1 O) 2 P(O)O] − , [(H 1 O)P(O)O 2 ] 2− , [(R 1 O)R 1 P(O)O] − , tosylate, malonate, which may be substituted by straight-chain or branched alkyl groups having 1 to 4 C atoms, [HOCO 2 ] − or [CO 3 ] 2− , where R 1 in each case, independently of one another, denotes a straight-chain or branched alkyl group having 1 to 12 C atoms and

R 2 in each case, independently of one another, denotes a straight-chain or branched perfluorinated alkyl group having 1 to 12 C atoms and where electroneutrality is taken into account in the formula of the salt KtA.

A perfluorinated linear or branched alkyl group having 1 to 4 C atoms is, for example, trifluoromethyl, pentafluoroethyl, n-heptafluoropropyl, iso-heptafluoropropyl, n-nonafluorobutyl, sec-nonafluorobutyl or tert-nonafluorobutyl. R 2 defines analogously a linear or branched perfluorinated alkyl group having 1 to 12 C atoms, encompassing the above-mentioned perfluoroalkyl groups and, for example, perfluorinated n-hexyl, perfluorinated n-heptyl, perfluorinated n-octyl, perfluorinated ethylhexyl, perfluorinated n-nonyl, perfluorinated n-decyl, perfluorinated n-undecyl or perfluorinated n-dodecyl.

R 2 is particularly preferably trifluoromethyl, pentafluoroethyl or nonafluorobutyl, very particularly preferably trifluoromethyl or pentafluoroethyl.

R 1 is particularly preferably methyl, ethyl, n-butyl, n-hexyl or n-octyl, very particularly preferably methyl or ethyl.

Substituted malonates are, for example, the compounds—methyl or ethyl malonate.

The anion A of the formula IV is preferably OH − , Cl − , Br − , I − , [CH 3 SO 3 ] − [CH 3 OSO 3 ] − , [CF 3 COO] − , [CF 3 SO 3 ] − , [(C 2 F 5 ) 2 P(O)O] − or [CO 3 ] 2− , particularly preferably OH − , Cl − , Br − , [CH 3 OSO 3 ] − , [CF 3 SO 3 ] − , [CH 3 SO 3 ] − or [(C 2 F 5 ) 2 P(O)O] − .

The organic cation for Kt is selected, for example, from ammonium cations, sulfonium cations, oxonium cations, phosphonium cations, uronium cations, thiouronium cations, guanidinium cations or heterocyclic cations, as described below, in particular by the formulae (1) to (8), or tritylium.

›Kt is particularly preferably an oxonium cation of…

Kt is particularly preferably an

oxonium cation of the formula

[(R o ) 3 O] +   (1)

or a sulfonium cation of the formula

[(R o ) 3 S] +   (2),

where R o in each case, independently of one another, denotes a straight-chain or branched alkyl group having 1-8 C atoms, unsubstituted phenyl, phenyl which is substituted by R 1 *, OR′, N(R′) 2 , CN or halogen or, restricted to sulfonium cations of the formula (2), (R′″) 2 N—,

where R′ in each case, independently of one another, denotes H, unfluorinated, partially fluorinated or perfluorinated linear or branched C 1 - to C 18 -alkyl, saturated C 3 - to C 7 -cycloalkyl, unsubstituted or substituted phenyl, R 1 * in each case, independently of one another, denotes unfluorinated, partially fluorinated or perfluorinated linear or branched C 1 - to C 18 -alkyl, saturated C 3 - to C 7 -cycloalkyl, unsubstituted or substituted phenyl and R′″ in each case, independently of one another, denotes linear or branched alkyl having 1 to 6 C atoms,

or an ammonium cation of the formula (3),

[NR 4 ] +   (3),

where

R in each case, independently of one another, denotes

H, OR′, N(R′) 2 , with the proviso that a maximum of one substituent R in formula (3) is OR′ or N(R′) 2 ,

straight-chain or branched alkyl having 1-20 C atoms,

straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds,

straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds,

saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms,

where one or two substituents R may be fully substituted by halogens, in particular —F and/or —Cl or where one or more substituents R may be partially substituted by halogens, in particular —F and/or —Cl, and/or by —OH, —OR′, —CN, —N(R′) 2 , —C(O)OH, —C(O)OR′, —C(O)R′, —C(O)N(R′) 2 , —SO 2 N(R′) 2 , —C(O)X, —SO 2 OH, —SO 2 X, —NO 2 , —SR′, —S(O)R′, —SO 2 R′,

and where one or two carbon atoms of the R which are not adjacent and are not in the α-position may be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO 2 —, —SO 2 O—, —C(O)—, —C(O)O—, —N + (R′ 2 )—, —P(O)R′O—, —C(O)NR′—, —SO 2 NR′—, —OP(O)R′O—, —P(O)(N(R′) 2 )NR′—, —P(R′) 2 ═N— or —P(O)R′—, where R′ in each case, independently of one another, denotes H, unfluorinated, partially fluorinated or perfluorinated, linear or branched C 1 - to C 18 -alkyl, saturated C 3 - to C 7 -cycloalkyl, unsubstituted or substituted phenyl and X in each case, independently of one another, denotes halogen.

or a phosphonium cation of the formula (4),

[P(R 2 ) 4 ] +   (4),

where

R 2 in each case, independently of one another, denotes

H, OR′ or N(R′) 2 ,

straight-chain or branched alkyl having 1-20 C atoms,

straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds,

straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds,

saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms,

where one or two substituents R 2 may be fully substituted by halogens, in particular —F and/or —Cl or where one or more substituents R 2 may be partially substituted by halogens, in particular —F and/or —Cl, and/or by —OH, —OR′, —CN, —N(R′) 2 , —C(O)OH, —C(O)OR′, —C(O)R′, —C(O)N(R′) 2 , —SO 2 N(R′) 2 , —C(O)X, —SO 2 OH, —SO 2 X, —NO 2 , —SR′, —S(O)R′, —SO 2 R′,

and where one or two carbon atoms of the R 2 which are not adjacent and are not in the α-position may be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO 2 —, —SO 2 O—, —C(O)—, —C(O)O—, —N + (R′ 2 )—, —P(O)R′O—, —C(O)NR′—, —SO 2 NR′—, —OP(O)R′O—, —P(O)(N(R′) 2 )NR′—, —P(R′) 2 ═N— or —P(O)R′—, where R′ in each case, independently of one another, denotes H, unfluorinated, partially fluorinated or perfluorinated, linear or branched C 1 - to C 18 -alkyl, saturated C 3 - to C 7 -cycloalkyl, unsubstituted or substituted phenyl and X in each case, independently of one another, denotes halogen,

or a uronium cation of the formula (5),

[C(NR 3 R 4 )(OR 5 )(NR 6 R 7 )] +   (5),

or that Kt is a thiouronium cation of the formula (6),

[C(NR 3 R 4 )(SR 5 )(NR 6 R 7 )] +   (6),

where

R 3 to R 7 each, independently of one another, denote

H, where H is excluded for R 5 ,

straight-chain or branched alkyl having 1 to 20 C atoms,

straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds,

straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds,

saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms,

where one or two of the substituents R 3 to R 7 may be fully substituted by halogens, in particular —F and/or —Cl, and one or more of the substituents R 3 to R 7 may be partially substituted by halogens, in particular —F and/or —CI, and/or —OH, —OR′, —N(R′) 2 , —CN, —C(O)OH, —C(O)OR′, —C(O)R′, —C(O)N(R′) 2 , —SO 2 NR′ 2 , —C(O)X, —SO 2 OH, —SO 2 X, —SR′, —S(O)R′, —SO 2 R′, —NO 2 and where one or two carbon atoms of R 3 to R 7 which are not adjacent and are not in the α-position may be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO 2 —, —SO 2 O—, —C(O)—, —C(O)O—, —N + (R′) 2 )—, —P(O)R′O—, —C(O)NR′—, —SO 2 NR′—, —OP(O)R′O—, —P(O)(N(R′) 2 )NR′—, —P(R′) 2 ═N— or —P(O)R′—, where R′ in each case, independently of one another, denotes H, unfluorinated, partially fluorinated or perfluorinated, linear or branched C 1 - to C 18 -alkyl, saturated C 3 - to C 7 -cycloalkyl, unsubstituted or substituted phenyl and X in each case, independently of one another, denotes halogen,

or a guanidinium cation of the formula (7),

[C(NR 8 R 9 )(NR 10 R 11 )(NR 12 R 13 )] +   (7),

where

R 8 to R 13 each, independently of one another, denote

H, —CN, N(R′) 2 , —OR′,

straight-chain or branched alkyl having 1 to 20 C atoms,

straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds,

›straight-chain or branched alkynyl having 2-20 C atoms…

straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds,

saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms,

where one or two of the substituents R 8 to R 13 may be fully substituted by halogens, in particular —F and/or —Cl, and one or more of the substituents R 8 to R 13 may be partially substituted by halogens, in particular —F and/or —Cl, and/or —OH, —OR′, —N(R′) 2 , —CN, —C(O)OH, —C(O)OR′, —C(O)R′, —C(O)N(R′) 2 , —SO 2 N(R′) 2 , —C(O)X, —SO 2 OH, —SO 2 X, —SR′, —S(O)R′, —SO 2 R′, —NO 2 and where one or two carbon atoms of R 8 to R 13 which are not adjacent and are not in the α-position may be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO 2 —, —SO 2 O—, —C(O)—, —C(O)O—, —N + (R′ 2 )—, —P(O)R′O—, —C(O)NR′—, —SO 2 NR′—, —OP(O)R′O—, —P(O)(N(R′) 2 )NR′—, —P(R′) 2 ═N— or —P(O)R′—, where R′ in each case, independently of one another, denotes H, unfluorinated, partially fluorinated or perfluorinated, linear or branched C 1 - to C 18 -alkyl, saturated C 3 - to C 7 -cycloalkyl, unsubstituted or substituted phenyl and X in each case, independently of one another, denotes halogen,

or a heterocyclic cation of the formula (8),

[HetN] z+   (8),

where

HetN z+ denotes a heterocyclic cation selected from the group

where the substituents

R 1′ to R 4′ each, independently of one another, denote

H, with the proviso that R 1′ and R 4′ are not together H,

straight-chain or branched alkyl having 1-20 C atoms,

straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds,

straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds,

saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms,

saturated, partially or fully unsaturated heteroaryl,

heteroaryl-C 1 -C 6 -alkyl or aryl-C 1 -C 6 -alkyl and

R 2′ additionally denotes F, Cl, Br, I, —CN, —OR′, —N(R′) 2 , —P(O)R′ 2 , —P(O)(OR′) 2 , —P(O)(N(R′) 2 ) 2 , —C(O)R′, —C(O)OR′, —C(O)X, —C(O)N(R′) 2 , —SO 2 N(R′) 2 , —SO 2 OH, —SO 2 X, —SR′, —S(O)R′, —SO 2 R′ and/or NO 2 , with the proviso that R 1′ , R 3′ and R 4′ are then each, independently of one another, H and/or a straight-chain or branched alkyl having 1-20 C atoms and/or a straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds,

where the substituents R 1′ , R 2′ , R 3′ and/or R 4′ together may also form a ring system,

where one, two or three substituents R 1′ to R 4′ may be fully substituted by halogens, in particular —F and/or —Cl, and one or more substituents R 1′ to R 4′ may be partially substituted by halogens, in particular —F and/or —Cl, and/or —OH, —OR′, —N(R′) 2 , —CN, —C(O)OH, —C(O)OR′, —C(O)R′, —C(O)N(R′) 2 , —SO 2 N(R′) 2 , —C(O)X, —SO 2 OH, —SO 2 X, —SR′, —S(O)R′, —SO 2 R′, —NO 2 , but where R 1′ and R 4′ cannot simultaneously be fully substituted by halogens,

and where one or two carbon atoms of the substituents R 1′ to R 4′ which are not adjacent and are not bonded to the heteroatom may be replaced by atoms and/or atom groups selected from —O—, —S—, —S(O)—, —SO 2 —, —SO 2 O—, —C(O)—, —C(O)O—, —N + (R′ 2 )—, —P(O)R′O—, —C(O)NR′—, —SO 2 NR′—, —OP(O)R′O—, —P(O)(N(R′) 2 )NR′—, —P(R′) 2 ═N— or —P(O)R′—, where R′ in each case, independently of one another, denotes H, unfluorinated, partially fluorinated or perfluorinated, linear or branched C 1 - to C 18 -alkyl, saturated C 3 - to C 7 -cycloalkyl, unsubstituted or substituted phenyl and X in each case, independently of one another, denotes halogen,

or a tritylium cation,

or a metal cation from groups 1 to 12 of the Periodic Table, selected from alkali-metal cations, Ag + , Mg 2+ , Cu + , Cu 2+ , Zn 2+ , Ca 2+ , Y +3 , Yb +3 , La +3 , Sc +3 , Ce +3 , Nd +3 , Tb +3 , Sm +3 or complex (ligand-containing) metal cations which contain rare-earth, transition or noble metals, such as rhodium, ruthenium, iridium, palladium, platinum, osmium, cobalt, nickel, iron, chromium, molybdenum, tungsten, vanadium, titanium, zirconium, hafnium, thorium, uranium, gold.

Fully unsaturated cycloalkyl substituents in the sense of the present invention are also taken to mean aromatic substituents.

Suitable substituents R and R 2 to R 13 of the compounds of the formulae (1) to (7) in accordance with the invention are, besides H, preferably: straight-chain or branched C 1 - to C 20 —, in particular C 1 - to C 14 -alkyl groups, and saturated or unsaturated, i.e. also aromatic, C 3 - to C 7 -cycloalkyl groups, which may be substituted by straight-chain or branched C 1 - to C 6 -alkyl groups, in particular phenyl.

The substituents R 0 , R and R 2 in the compounds of the formula (1), (2), (3) or (4) may be identical or different here. In compounds of the formulae (1), preferably two or three substituents R o are identical. In compounds of the formulae (2), preferably all substituents R o are identical or two are identical and one substituent is different. In compounds of the formula (3), preferably three or four substituents R are identical. In compounds of the formula (4), preferably three or four substituents R 2 are identical.

The substituents R and R 2 are particularly preferably methyl, ethyl, isopropyl, propyl, butyl, sec-butyl, pentyl, hexyl, octyl, decyl or tetradecyl.

Up to four substituents of the guanidinium cation [C(NR 8 R 9 )(NR 10 R 11 )—(NR 12 R 13 )] + may also be connected in pairs in such a way that mono-, bi- or polycyclic molecules form.

Without restricting generality, examples of guanidinium cations of this type are:

where the substituents R 8 to R 10 and R 13 can have an above-mentioned or particularly preferred meaning.

The carbocycles or heterocycles of the above-mentioned guanidinium cations may optionally also be substituted by straight-chain or branched C 1 - to C 6 -alkyl, straight-chain or branched C 1 - to C 6 -alkenyl, —CN, —NO 2 , —OH, —F, —CI, —Br, I, straight-chain or branched C 1 -C 6 -alkoxy, —N(R′) 2 , —SR′, —S(O)R′, —SO 2 R′, —COOH, —C(O)OR′, —C(O)R′, —C(O)N(R′) 2 , —SO 2 N(R′) 2 , —C(O)X, —SO 2 X, —SO 3 H, substituted or unsubstituted phenyl or unsubstituted or substituted heterocycle, where X and R′ have an above-mentioned meaning.

›Up to four substituents of the thiouronium cation…

Up to four substituents of the thiouronium cation [C(NR 3 R 4 )(SR 5 )(NR 6 R 7 )] + or of the uronium cation [C(NR 3 R 4 )(OR 5 )(NR 6 R 7 )] + may also be connected in pairs in such a way that mono-, bi- or polycyclic molecules arise.

Without restricting generality, examples of uronium cations or thiouronium cations of this type are indicated below:

in which Y═S or O

and where the substituents R 3 , R 5 and R 6 may have an above-mentioned or particularly preferred meaning.

The carbocycles or heterocycles of the above-mentioned guanidinium cations may optionally also be substituted by straight-chain or branched C 1 - to C 6 -alkyl, straight-chain or branched C 1 - to C 6 -alkenyl, —CN, —NO 2 , —OH, —F, —CI, —Br, I, straight-chain or branched C 1 -C 6 -alkoxy, —N(R′) 2 , —SR′, —S(O)R′, —SO 2 R′, —COOH, —C(O)OR′, —C(O)R′, —C(O)N(R′) 2 , —SO 2 N(R′) 2 , —C(O)X, —SO 2 X, —SO 3 H, substituted or unsubstituted phenyl or unsubstituted or substituted heterocycle, where X and R′ have an above-mentioned meaning.

The substituents R 3 to R 13 are each, independently of one another, preferably a straight-chain or branched alkyl group having 1 to 10 C atoms. The substituents R 3 and R 4 , R 6 and R 7 , R 8 and R 9 , R 10 and R 11 and R 12 and R 13 in compounds of the formulae (5) to (7) may be identical or different here. R 3 to R 13 are particularly preferably each, independently of one another, methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, sec-butyl, phenyl or cyclohexyl, very particularly preferably methyl, ethyl, n-propyl, isopropyl or n-butyl.

Suitable substituents R 1′ and R 4′ of compounds of the formula (8) are in each case, independently of one another, preferably: straight-chain or branched C 1 - to C 20 , in particular C 1 - to C 12 -alkyl groups, where one or two carbon atoms which are not adjacent and are not bonded to the heteroatom may be replaced by O, and saturated or unsaturated, i.e. also aromatic, C 3 - to C 7 -cycloalkyl groups, which may be substituted by straight-chain or branched C 1 - to C 6 -alkyl groups, in particular phenyl.

The substituents R 1′ and R 4′ are each, independently of one another, particularly preferably methyl, ethyl, isopropyl, propyl, butyl, sec-butyl, pentyl, hexyl, octyl, decyl, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxymethyl, cyclohexyl, phenyl or benzyl. They are very particularly preferably methyl, ethyl, n-butyl or n-hexyl. In pyrrolidine, piperidine, indoline, pyrrolidinium, piperidinium or indolinium compounds, the two substituents R 1′ and R 4′ are preferably different.

The substituent R 2′ or R 3′ is in each case, independently of one another, in particular H, methyl, ethyl, isopropyl, propyl, butyl, sec-butyl, tert-butyl, cyclohexyl, phenyl or benzyl. R 2′ is particularly preferably H, methyl, ethyl, isopropyl, propyl, butyl or sec-butyl. R 2′ and R 3′ are very particularly preferably H.

A straight-chain or branched alkenyl having 2 to 20 C atoms, where a plurality of double bonds may also be present, is, for example, allyl, 2- or 3-butenyl, isobutenyl, sec-butenyl, furthermore 4-pentenyl, isopentenyl, hexenyl, heptenyl, octenyl, —C 9 H 17 , —C 10 H 19 to —C 20 H 39 ; preferably allyl, 2- or 3-butenyl, isobutenyl, sec-butenyl, preference is furthermore given to 4-pentenyl, isopentenyl or hexenyl. If the compounds are partially fluorinated, at least one H atom is replaced by an F atom. If the compounds are perfluorinated, all H atoms of the corresponding alkyl group have been replaced by F atoms.

A straight-chain or branched alkynyl having 2 to 20 C atoms, where a plurality of triple bonds may also be present, is, for example, ethynyl, 1- or 2-propynyl, 2- or 3-butynyl, furthermore 4-pentynyl, 3-pentynyl, hexynyl, heptynyl, octynyl, —C 9 H 15 , —C 10 H 17 to —C 20 H 37 , preferably ethynyl, 1- or 2-propynyl, 2- or 3-butynyl, 4-pentynyl, 3-pentynyl or hexynyl. If the compounds are partially fluorinated, at least one H atom is replaced by an F atom. If the compounds are perfluorinated, all H atoms of the corresponding alkyl group have been replaced by F atoms.

Aryl-C 1 -C 6 -alkyl denotes, for example, benzyl, phenylethyl, phenylpropyl, phenylbutyl, phenylpentyl or phenylhexyl, where both the phenyl ring and also the alkylene chain may be partially or fully substituted, as described above, by halogens, in particular —F and/or —CI, or partially by —OH, —OR′, —N(R′) 2 , —CN, —C(O)OH, —C(O)N(R′) 2 , —SO 2 N(R′) 2 , —C(O)X, —C(O)OR′, —C(O)R′, —SO 2 OH, —SO 2 X, SR′, —S(O)R′, —SO 2 R′ or NO 2 , where R′ and X have an above-mentioned meaning

Unsubstituted saturated or partially or fully unsaturated cycloalkyl groups having 3-7 C atoms are therefore cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentenyl, cyclohexenyl, phenyl, cycloheptenyl, each of which may be substituted by straight-chain or branched C 1 - to C 6 -alkyl groups, where the cycloalkyl group or the cycloalkyl group which is substituted by straight-chain or branched C 1 - to C 6 -alkyl groups may in turn also be substituted by halogen atoms, such as F, Cl, Br or I, in particular F or CI, or by —OH, —OR′, —N(R′) 2 , —CN, —C(O)OH, —C(O)N(R′) 2 , —SO 2 N(R′) 2 , —C(O)X, —C(O)OR′, —C(O)R′, —SO 2 OH, —SO 2 X, SR′, —S(O)R′, —SO 2 R′ or NO 2 , where R′ and X have an above-mentioned meaning.

In the substituents R, R 2 to R 13 or R 1′ to R 4′ , one or two carbon atoms which are not adjacent and are not bonded in the α-position to the heteroatom may also be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO 2 —, —SO 2 O—, —C(O)—, —C(O)O—, —N + (R′) 2 − , —P(O)R′O—, —C(O)NR′—, —SO 2 NR′, —OP(O)R′O—, —P(O)(N(R′) 2 )NR′—, —P(R′) 2 ═N— or —P(O)R′, where R′ has an above-mentioned meaning.

Halogen denotes F, Cl, Br or I, preferably F, CI or Br, particularly preferably F or Cl.

In R′ or R 1 *, C 3 - to C 7 -cycloalkyl is, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or cycloheptyl.

In R′ or R 1 *, substituted phenyl denotes phenyl which is substituted by straight-chain or branched C 1 - to C 6 -alkyl, straight-chain or branched C 1 - to C 6 -alkenyl, CN, N(R″) 2 , —NO 2 , F, Cl, Br, I, —OH, straight-chain or branched C 1 -C 6 -alkoxy, —COOH, —C(O)OR″, —C(O)R″, —SO 2 X′, —SR″, —S(O)R″, —SO 2 R″, SO 2 N(R″) 2 or SO 3 H, where R* denotes an unfluorinated, partially fluorinated or perfluorinated straight-chain or branched C 1 - to C 6 -alkyl or C 3 - to C 7 -cycloalkyl and where X′ denotes F, CI or Br, for example, o-, m- or p-methylphenyl, o-, m- or p-ethylphenyl, o-, m- or p-propylphenyl, o-, m- or p-isopropylphenyl, o-, m- or p-(tert-butyl)phenyl, o-, m- or p-methoxyphenyl, o-, m- or p-ethoxyphenyl, o-, m-, p-(trifluoromethyl)phenyl, o-, m-, p(trifluoromethoxy)phenyl, o-, m-, p-(trifluoromethylsulfonyl)phenyl, o-, m- or p-fluorophenyl, o-, m- or p-chlorophenyl, o-, m- or p-bromophenyl, o-, m- or p-iodophenyl, further preferably 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dimethylphenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dihydroxyphenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-difluorophenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dichlorophenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dibromophenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dimethoxyphenyl, 5-fluoro-2-methylphenyl, 3,4,5-trimethoxyphenyl or 2,4,5-trimethylphenyl.

›In R 1′ to R 4′ , heteroaryl…

In R 1′ to R 4′ , heteroaryl is taken to mean a saturated or unsaturated mono- or bicyclic heterocyclic radical having 5 to 13 ring members, where 1, 2 or 3 N and/or 1 or 2 S or O atoms may be present and the heterocyclic radical may be mono- or polysubstituted by straight-chain or branched C 1 - to C 6 -alkyl, straight-chain or branched C 1 - to C 6 -alkenyl, CN, N(R″) 2 , OH, NO 2 , F, CI, Br, I, straight-chain or branched C 1 -C 6 -alkoxy, —COOH, —C(O)OR″, —C(O)R″, —SO 2 X′, —SO 2 N(R″) 2 , —SR″, —S(O)R″, —SO 2 R″ or SO 3 H, where R″ and X have an above-mentioned meaning.

The heterocyclic radical is preferably substituted or unsubstituted 2- or 3-furyl, 2- or 3-thienyl, 1-, 2- or 3-pyrrolyl, 1-, 2-, 4- or 5-imidazolyl, 3-, 4- or 5-pyrazolyl, 2-, 4- or 5-oxazolyl, 3-, 4- or 5-isoxazolyl, 2-, 4- or 5-thiazolyl, 3-, 4- or 5-isothiazolyl, 2-, 3- or 4-pyridyl, 2-, 4-, 5- or 6-pyrimidinyl, furthermore preferably 1,2,3-triazol-1-, -4- or -5-yl, 1,2,4-triazol-1-, -4- or -5-yl, 1- or 5-tetrazolyl, 1,2,3-oxadiazol-4- or -5-yl 1,2,4-oxadiazol-3- or -5-yl, 1,3,4-thiadiazol-2- or -5-yl, 1,2,4-thiadiazol-3- or -5-yl, 1,2,3-thiadiazol-4- or -5-yl, 2-, 3-, 4-, 5- or 6-2H-thiopyranyl, 2-, 3- or 4-4H-thiopyranyl, 3- or 4-pyridazinyl, pyrazinyl, 2-, 3-, 4-, 5-, 6- or 7-benzofuryl, 2-, 3-, 4-, 5-, 6- or 7-benzothienyl, 1-, 2-, 3-, 4-, 5-, 6- or 7-1H-indolyl, 1-, 2-, 4- or 5-benzimidazolyl, 1-, 3-, 4-, 5-, 6- or 7-benzopyrazolyl, 2-, 4-, 5-, 6- or 7-benzoxazolyl, 3-, 4-, 5-, 6- or 7-benzisoxazolyl, 2-, 4-, 5-, 6- or 7-benzothiazolyl, 2-, 4-, 5-, 6- or 7-benzisothiazolyl, 4-, 5-, 6- or 7-benz-2,1,3-oxadiazolyl, 1-, 2-, 3-, 4-, 5-, 6-, 7- or 8-quinolinyl, 1-, 3-, 4-, 5-, 6-, 7- or 8-isoquinolinyl, 1-, 2-, 3-, 4- or 9-carbazolyl, 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-acridinyl, 3-, 4-, 5-, 6-, 7- or 8-cinnolinyl, 2-, 4-, 5-, 6-, 7- or 8-quinazolinyl or 1-, 2- or 3-pyrrolidinyl.

Heteroaryl-C 1 -C 6 -alkyl is now taken to mean, analogously to aryl-C 1 -C 6 -alkyl, for example, pyridinylmethyl, pyridinylethyl, pyridinylpropyl, pyridinylbutyl, pyridinylpentyl, pyridinylhexyl, where furthermore the heterocycles described above may be linked to the alkylene chain in this way.

HetN + is preferably

where the substituents R 1′ to R 4′ each, independently of one another, have a meaning described above.

The organic cation Kt is particularly preferably selected from the group comprising imidazolium, pyridinium, pyrrolidinium, ammonium or phosphonium cations, as defined above by the formulae indicated and the substituents indicated.

The salt-exchange reaction of the compounds of the formula I with compounds of the formula IV, as described above, is advantageously carried out in water, where temperatures of 0°-100° C., preferably 15°-60° C., are suitable. The reaction is particularly preferably carried out at room temperature (25° C.).

However, the above-mentioned salt-exchange reaction may alternatively also be carried out in organic solvents at temperatures between −30° and 100° C. Suitable solvents here are acetonitrile, dioxane, dichloromethane, dimethoxyethane, dimethyl sulfoxide, tetrahydrofuran, dimethylformamide or alcohol, for example methanol, ethanol or isopropanol.

The following working examples are intended to explain the invention without limiting it. The invention can be carried out correspondingly throughout the range claimed. Possible variants can also be derived starting from the examples. In particular, the features and conditions of the reactions described in the examples can also be applied to other reactions which are not shown in detail, but fall within the scope of protection of the claims.

›EXAMPLES

The substances obtained are characterised by means of NMR spectra and X-ray structural analysis. The NMR spectra are measured on solutions in deuterated acetone-D 6 or in CD 3 CN in a Bruker Avance III spectrometer with deuterium lock. The measurement frequencies of the various nuclei are: 1 H: 400.17 MHz, 11 B: 128.39 MHz, 31 P: 161.99 MHz and 13 C: 100.61 MHz. The referencing is carried out with an external reference: TMS for 1 H and 13 C spectra and BF 3 .Et 2 O— for 11 B spectra.

›Examples9
›Example 1

Sodium Dicyanodihydridoborate—Na[BH 2 (CN) 2 ]

NaBH 4 +2Me 3 SiCN→Na[BH 2 (CN) 2 ]+2Me 3 SiH

37.83 g (1.00 mol) of NaBH 4 and 302 g (3.04 mol) of trimethylsilyl cyanide, Me 3 SiCN, are warmed under reflux in inert atmosphere for 2 days (oil-bath temperature is 150° C.). Trimethylsilane, Me 3 SiH (b.p. 6.7° C.), formed is collected in a flask in an ice bath. After cooling, the liquid reaction mixture becomes predominantly solid. Excess trimethylsilyl cyanide, Me 3 SiCN (101.24 g, 1.02 mol, 98% of the theoretical amount), is removed from the product Na[BH 2 (CN) 2 ] in vacuo. Na[BH 2 (CN) 2 ] is dried in vacuo. The yield is 87.85 g (1.00 mol, 100%).

X-ray structure, Na[BH 2 (CN) 2 ]: a=7.8136 (3), b=7.8656 (4), c=16.1764 (7) Å, α=78.489 (4), β=76.882 (3), γ=72.197 (4)°, V=912.75, Z=8, P−1, T=150 K. 1 H{ 11 B}-NMR (solvent: CD 3 CN; reference: TMS): δ, ppm=0.99 s (2H, BH 2 ).

11 B-NMR (solvent: CD 3 CN; reference: Et 2 O.BF 3 ): δ, ppm=−42.2 t, 1 J B,H =95 Hz.

›Example 2

Potassium Dicyanodihydridoborate—K[BH 2 (CN) 2 ]

2Na[BH 2 (CN) 2 ]+K 2 CO 3 →2K[BH 2 (CN) 2 ]+Na 2 CO 3

24.8 g (0.282 mol) of sodium dicyanodihydridoborate, Na[BH 2 (CN) 2 ], are dissolved in about 20 ml of water and reacted with 30.2 g (0.219 mol) of K 2 CO 3 . The solution is diluted with 260 ml of tetrahydrofuran and stirred vigorously. The organic phase is separated off, dried using K 2 CO 3 , the tetrahydrofuran is distilled off, and the residue is dried in vacuo. The yield of potassium dicyanodihydridoborate, K[BH 2 (CN) 2 ], is 28.1 g (0.270 mol, 96%) The product is characterised by means of NMR spectra and X-ray analysis. X-ray structure, K[BH 2 (CN) 2 ]: a=7.3073 (3), b=9.5312 (3), c=7.3659 (3) Å, α=90, β=109.965 (5), γ=90°, V=482.18 Z=4, P2 1 /c, T=150 K.

›Example 3

1-Ethyl-3-methylimidazolium dicyanodihydridoborate—EMIM [BH 2 (CN) 2 ]

14.04 g (135 mmol) of potassium dicyanodihydridoborate, K[BH 2 (CN) 2 ], and 19.8 g (135 mmol) of 1-ethyl-3-methylimidazolium chloride, [EMIM]Cl, are each dissolved in 20 ml of water and mixed. 1-Ethyl-3-methylimidazolium dicyanodihydridoborate, [EMIM][BH 2 (CN) 2 ], is extracted with 130+50+50 ml of CH 2 Cl 2 . The combined organic phases are washed with 80 ml of water, dried using Na 2 SO 4 , and the solvent is distilled off. [EMIM][BH 2 (CN) 2 ] is dried at about 50° C. in vacuo for two days with stirring. The yield is 16.3 g (93 mmol, 69%).

Water content: 44 ppm; chloride content: 18 ppm;

viscosity: 10.2 mPa·s (20° C.).

Decomposition temperature (onset): about 290° C. (DSC/TGA)

11 B NMR (solvent: CD 3 CN; reference: Et 2 O.BF 3 ), δ, ppm: −42.0 t, 1 J H,B =95 Hz.

1 H{ 11 B} NMR (solvent: CD 3 CN; reference: TMS), δ, ppm: 8.56 br.s (1H, CH); 7.45 d, d (1H, CH), 3 J H,H =1.8 Hz; 7.39 d, d (1H, CH), 3 J H,H =1.7 Hz; 4.20 q (2H, CH 2 ), 3 J H,H =7.3 Hz; 3.86 s (3H, CH 3 ); 1.48 t (3H, CH 3 ), 3 J H,H =7.3; 0.93 br. s (2H, BH 2 ).

›Example 4

1-Butyl-1-methylpyrrolidinium dicyanodihydridoborate—BMPL [BH 2 (CN) 2 ]

13.9 (134 mmol) g of potassium dicyanodihydridoborate, K[BH 2 (CN) 2 ], and 23.8 g (134 mmol) of 1-butyl-1-methylpyrrolidinium chloride, [BMPL]Cl, are each dissolved in 20 ml of water and mixed. The product, 1-butyl-1-methylpyrrolidinium dicyanodihydridoborate, [BMPL][BH 2 (CN) 2 ], is extracted with 100+100+50 ml of CH 2 Cl 2 . The combined organic phase are washed with 100 ml of water, dried using Na 2 SO 4 , and the solvent is distilled off. [BMPL][BH 2 (CN) 2 ] is dried at about 50° C. in vacuo for two days with stirring. The yield of 1-butyl-1-methylpyrrolidinium dicyanodihydridoborate is 23.0 g (111 mmol, 83%).

Chloride content: 21 ppm;

viscosity: 23.6 mPa·s (20° C.).

11 B NMR (solvent: CD 3 CN; reference: Et 2 O.BF 3 ), δ, ppm:

−42.0 t, 1 J H,B =94 Hz.

1 H{ 11 B} NMR (solvent: CD 3 CN; reference: TMS), δ, ppm: 3.45 m (4H, 2CH 2′ ); 3.27 m (2H, CH 2 ); 2.99 s (3H, CH 3 ); 2.19 m (4H, 2CH 2 ); 1.75 m (2H, CH 2 ); 1.40 m (2H, CH 2 ); 0.98 t (3H, CH 3 ), 3 J H,H =7.3 Hz; 1.01 s (2H, BH 2 ).

›Example 5

N,N,N-Tributyl-N-methylammonium dicyanodihydridoborate—[(n-C 4 H 9 ) 3 CH 3 N][BH 2 (CN) 2 ]

6.68 g (76 mmol) of sodium dicyanodihydridoborate, Na[BH 2 (CN) 2 ], and 17.98 g (76 mmol) of N,N,N-tributyl-N-methylammonium chloride, [(n-C 4 H 9 ) 3 CH 3 N]Cl, are each dissolved in 20 ml of water and mixed. The product, N,N,N-tributyl-N-methylammonium dicyanodihydridoborate, [(n-C 4 H 9 ) 3 CH 3 N][BH 2 (CN) 2 ], is extracted with 100+50+50 ml of CH 2 Cl 2 . The combined organic phases are washed with 100 ml of water, dried using Na 2 SO 4 , and the solvent is distilled off. [(n-C 4 H 9 ) 3 CH 3 N][BH 2 (CN) 2 ] is dried at about 50° C. in vacuo for two days with stirring. The yield of tributylmethylammonium dicyanodihydridoborate is 20.0 g (75 mmol, 99%).

Water content: 17 ppm; chloride content: <5 ppm;

viscosity: 158 mPa·s (20° C.).

Decomposition temperature (onset): about 275° C. (DSC/TGA)

1 H{ 11 B}-NMR (solvent: CD 3 CN; reference: TMS): δ, ppm=0.97 t (3CH 3 , 9H), 3 J H,H =7.5 Hz; 1.02 s (2H, BH 2 ); 1.38 m (3CH 2 , 6H); 1.62-1.73 m (3CH 2 , 6H); 2.94 s (CH 3 , 3H), 3.19 m, (3CH 2 , 6H).

11 B-NMR (solvent: CD 3 CN; reference: Et 2 O.BF 3 ): δ, ppm=−41.8 t, 1 J B,H =94 Hz.

›Example 6

Tetrabutylammonium dicyanodihydridoborate—[(n-C 4 H 9 ) 4 N][BH 2 (CN) 2 ]

Analogously to Example 5, 5.72 g (65 mmol) of sodium dicyanodihydridoborate, Na[BH 2 (CN) 2 ], are mixed with 45 ml of 40% aqueous tetrabutylammonium hydroxide, [(n-C 4 H 9 ) 4 N]OH, and subjected to appropriate work-up. The yield of tetrabutylammonium dicyanodihydridoborate is 19.0 g (62 mmol, 95%).

The product was characterised by means of NMR spectra and X-ray analysis.

Water content: 360 ppm; chloride content: 19 ppm; melting point: 55° C.

Decomposition temperature (onset): about 275° C. (DSC/TGA)

X-ray structure, [(n-C 4 H 9 ) 4 N][BH 2 (CN) 2 ]: a=9.4272 (3), b=14.5252 (4), c=15.3664 (5) Å, α=90, β=97.058 (3), γ=90°, V=2088.20, Z=4, P2 1 /n, T=110 K.

1 H{ 11 B}-NMR (solvent: acetone-D 6 ; reference: TMS): δ, ppm=1.00 t (4CH 3 , 12H), 3 J H,H =7.5 Hz; 1.11 s (2H, BH 2 ); 1.45 m (4CH 2 , 8H); 1.82 m (4CH 2 , 8H); 3.42 m, (4CH 2 , 8H).

11 B-NMR (solvent: acetone-D 6 ; reference: Et 2 O.BF 3 ): δ, ppm=−41.8 t, 1 J B,H =94 Hz.

›Example 7

Tetraethylammonium dicyanodihydridoborate—[(C 2 H 5 ) 4 N][BH 2 (CN) 2 ]

Analogously to Example 5, 9.0 g (103 mmol) of sodium dicyanodihydridoborate, Na[BH 2 (CN) 2 ], are mixed with 79.5 ml of 20% aqueous tetraethylammonium hydroxide, [(C 2 H 5 ) 4 N]OH, and subjected to appropriate work-up. The yield of tetraethylammonium dicyanodihydridoborate is 16.0 g (82 mmol, 80%).

Water content: 192 ppm; chloride content: 30 ppm; melting point: 43° C.

Decomposition temperature (onset): 267° C. (DSC/TGA)

1 H{ 11 B}-NMR (solvent: acetone-D 6 ; reference: TMS): δ, ppm=1.37 t, t (4CH 3 , 12H), 3 J H,H =7.2 Hz, 3 J H,N =1.9 Hz; 1.07 s (2H, BH 2 ); 3.44 q (4CH 2 , 8H), 3 J H,H =7.2 Hz.

11 B-NMR (solvent: acetone-D 6 ; reference: Et 2 O.BF 3 ): δ, ppm=−41.7 t, 1 J B,H =94 Hz.

›Example 8

Tetrabutylphosphonium dicyanodihydridoborate—[(n-C 4 H 9 ) 4 P][BH 2 (CN) 2 ]

Analogously to Example 5, 5.43 g (62 mmol) of sodium dicyanodihydridoborate, Na[BH 2 (CN) 2 ], are mixed with 45 ml of 40% aqueous tetrabutylphosphonium hydroxide, [(n-C 4 H 9 ) 4 P]OH, and subjected to appropriate work-up. [(n-C 4 H 9 ) 4 P][BH 2 (CN) 2 ] is dried at about 60° C. in vacuo for two days with stirring. The yield of tetrabutylphosphonium dicyanodihydridoborate is 19.0 g (59 mmol, 95%).

Water content: 372 ppm; chloride content: 16 ppm; melting point: 42° C.

Decomposition temperature (onset): 361° C. (DSC/TGA)

1 H{ 11 B}-NMR (solvent: acetone-D 6 ; reference: TMS): δ, ppm=0.98 t (4CH 3 , 12H), 3 J H,H =7.3 Hz; 1.11 br. s (2H, BH 2 ); 1.54 m (4CH 2 , 8H); 1.65-1.76 m (4CH 2 , 8H); 2.35-2.45 m, (4CH 2 , 8H).

11 B-NMR (solvent: acetone-D 6 ; reference: Et 2 O.BF 3 ): δ, ppm=−41.7 t, 1 J B,H =94 Hz.

›Example 9

1-Butyl-3-methylpyridinium dicyanodihydridoborate—[BMPy][BH 2 (CN) 2 ]

4.09 g (46.6 mmol) of sodium dicyanodihydridoborate, Na[BH 2 (CN) 2 ], and 8.63 g (46.5 mmol) of 1-butyl-3-methylpyridinium chloride, [BMPy]Cl, are each dissolved in 20 ml of water and mixed. The product, 1-butyl-3-methylpyridinium dicyanodihydridoborate, [BMPy][BH 2 (CN) 2 ], is extracted with 100+100+50 ml of CH 2 Cl 2 . The combined organic phases are washed with 50+50 ml of water, dried using Na 2 SO 4 , and the solvent is distilled off. [BMPy][BH 2 (CN) 2 ] is dried at about 40° C. in vacuo for one day with stirring. The yield of 1-butyl-3-methylpyridinium dicyanodihydridoborate is 9.0 g (41.8 mol, 90%).

1 H{ 11 B}-NMR (solvent: acetone-D 6 ; reference: TMS): δ, ppm=0.97 t (CH 3 , 3H), 3 J H,H =7.5 Hz; 1.02 s (2H, BH 2 ); 1.44 m (CH 2 , 2H); 2.08 m (CH 2 , 2H); 2.63 s (CH 3 , 3H), 4.71 t (CH 2 , 2H), 3 J H,H =7.6 Hz; 8.08 d, d (CH, 1H), 3 J H,H =7.0 Hz; 8.50 d (CH, 1H), 3 J H,H =8.1 Hz; 8.88 d (CH, 1H), 3 J H,H =6.1 Hz; 8.95 s (CH, 1H).

11 B{ 1 H}NMR (solvent: acetone-D 6 ; reference: Et 2 O.BF 3 ): δ, ppm=−41.7 s

6 of 16 part labels are ours — the grant heads the rest

Claims as granted

7 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

4 codes
IPC · International Patent Classification
Section C — Chemistry; metallurgy
  • C01B6/21
  • C07F5/02
USPC · US Patent Classification
546/13556/8

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomApr 2012Jul 2012Oct 2012Jan 2013Apr 2013Jul 2013Oct 2013Jan 2014Apr 2014Jul 2014Oct 2014Jan 2015USPTOApplicantNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
2.6 y
958 days filing → grant
Office actions
0
none on record
Responses
1
no RCE
Examiner
Charanjit Aulakh
art unit 1625 · TC 1600
Citations: 16 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom2014201620182020202220242026202820302032Owner 1liens, releases & corrections
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock